Extracorporeal membrane oxygenation in patients with hematologic malignancies: a systematic review and meta-analysis Jackie Jia Lin SimSaikat MitraKollengode Ramanathan Review Article 27 May 2022 Pages: 1395 - 1406
Increasing genomic discovery in newly diagnosed multiple myeloma: defining disease biology and its correlation to risk Patrick HagenMark SellinJiwang Zhang Review Article 18 May 2022 Pages: 1407 - 1420
Congenital asplenia study: clinical and laboratory characterisation of adults with congenital asplenia Grace I. Butel-SimoesPenelope JonesSamar Ojaimi Original Article 22 April 2022 Pages: 1421 - 1434
Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study Boram HanHyo Jung KimSoo-Mee Bang Original Article 28 May 2022 Pages: 1435 - 1445
Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case–control study in Chinese children Yuqing SongYuelun ZhangHongmei Song Original Article 09 May 2022 Pages: 1447 - 1456
Correction to: Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case–control study in Chinese children Yuqing SongYuelun ZhangHongmei Song Correction 24 May 2022 Pages: 1457 - 1457
Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia Lale Aydın KaynarSanem GökçenMünci Yağcı Original Article 23 April 2022 Pages: 1459 - 1464
Does size matter? Two new deletions in the HBB gene cause β0-thalassemia Paloma RoperoFernando Ataúlfo González FernándezCuesta C. Benavente Original Article 25 April 2022 Pages: 1465 - 1471
Left atrial deformation indices in β-thalassemia major patients Dimitrios PatsourakosConstantina AggeliKonstantinos Tsioufis Original Article 23 April 2022 Pages: 1473 - 1483
Screening for hereditary spherocytosis in daily practice: what is the best algorithm using erythrocyte and reticulocyte parameters? Anne-Sophie AdamFrédéric CottonBéatrice Gulbis Original Article 22 April 2022 Pages: 1485 - 1491
Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia Xuemei WuLang ChengJianyong Li Original Article 23 April 2022 Pages: 1493 - 1498
Characteristics of Sweet syndrome in patients with or without malignancy Eun Hee JungJin Hyun ParkInho Kim Original Article 28 April 2022 Pages: 1499 - 1508
Comparative efficacy and safety of eleven induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia: a network meta-analysis Yiqing LiTing TangDanian Nie Original Article 20 April 2022 Pages: 1509 - 1522
Mapping incidence and mortality of leukemia and its subtypes in 21 world regions in last three decades and projections to 2030 Rajesh SharmaChinmay Jani Original Article 10 May 2022 Pages: 1523 - 1534
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma Yong-Pyo LeeSang Eun YoonWon Seog Kim Original Article 31 May 2022 Pages: 1535 - 1543
The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma Na LiMing JiangLi-qun Zou Original Article 30 May 2022 Pages: 1545 - 1556
First-line LVDP (l-asparaginase, etoposide, dexamethasone, and cisplatin) regimen combined with radiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type Wanchun WuXi ChenLiqun Zou Original Article 18 May 2022 Pages: 1557 - 1565
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms Miren VallejoPaula MuñizIsmael Buño Original Article Open access 07 May 2022 Pages: 1567 - 1576
Myelolipoma/extramedullary hematopoiesis within adrenal cortical adenoma increased in size during chronic myelogenous leukemia treatment JinA BaekMin Kyoung KimMi-Jin Gu Letter to the Editor 28 January 2022 Pages: 1577 - 1578
A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion Lianqun QiuCesar A. NunezBeenu Thakral Letter to the Editor 28 January 2022 Pages: 1579 - 1581
Chronic neutropenic colitis with complete colonic obstruction in a patient with severe congenital neutropenia associated with G6PC3 mutations Taxiarchis Konstantinos NikolouzakisKonstantinos SpyridakisHelen A. Papadaki Letter to the Editor 27 January 2022 Pages: 1583 - 1585
Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine Mitsuhito HiranoMikako TambaDai Maruyama Letter to the Editor Open access 21 February 2022 Pages: 1587 - 1589
Red eye and visual loss in a bone marrow transplant recipient Magdalena Corona-LapuertaFernando Martin-MoroJavier López Letter to the Editor 31 January 2022 Pages: 1591 - 1592
Two cases of refractory IgG4-related disease successfully treated with tocilizumab Jeremy OngSusan BrownGareth Gregory Letter to the Editor 13 February 2022 Pages: 1593 - 1594
Anhidrosis associated with long-term use of hydroxyurea in a patient with myeloproliferative neoplasm Saad SabbaghKawthar JarrahAli T. Taher Letter to the Editor 12 February 2022 Pages: 1595 - 1596
A case report of BCR-ABL1 rearrangement in de novo adult T-cell lymphoblastic leukemia/lymphoma with normal karyotype Weijia FuAijie HuangXiong Ni Letter to the Editor 14 February 2022 Pages: 1597 - 1598
Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” Faith E. DaviesEleanor SaundersPatricia Guyot Letter to the Editor Open access 18 February 2022 Pages: 1599 - 1601
Combination therapy with low doses of ponatinib and steroids in elderly and frail patients with Philadelphia chromosome-positive acute lymphoblastic leukemia Takafumi TsushimaNobue SatoJunichiro Yuda Letter to the Editor 24 March 2022 Pages: 1603 - 1605
COVID-19: impact of vaccination in myeloma patients E. HoornaertF. DachyM-C. Vekemans Letter to the Editor 11 April 2022 Pages: 1607 - 1608
Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma Teruhito TakakuwaYusuke OkayamaMasayuki Hino Letter to the Editor 26 February 2022 Pages: 1609 - 1610
Prognostic impact of Auer rods for cytoreductive chemotherapy and myeloablative allogeneic stem cell transplantation in adult patients with myelodysplastic syndrome with excess blasts-2 Yi WangYaoyao ShenYing Wang Letter to the Editor 02 March 2022 Pages: 1611 - 1615
Successful treatment for diffuse large B-cell lymphoma in a Japanese adolescent with PIK3CD germ-line mutation: stem cell transplantation after reduced-intensity conditioning Hiroshi YagasakiMaiko HiraiIchiro Morioka Letter to the Editor 05 March 2022 Pages: 1617 - 1619
The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia Silvia CostantiniAntonella MeloniPaolo Ricchi Letter to the Editor 05 March 2022 Pages: 1621 - 1623
Correction to: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma Tan-Huy ChuSung-Hoon JungJe-Jung Lee Correction 23 May 2022 Pages: 1625 - 1625